← Alle mensen

PV

Patricia Villagrasa

8 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Gevorderd Breast Cancer...
Clinical cancer research : an official journal of the American Association for Cancer Research · 17 februari 2026
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analyse.
The Lancet. Oncology · 2025-08
HER2DX genomische test bij HER2-positief mammacarcinoom: APHINITY analyse
Clinical cancer research : an official journal of the American Association for Cancer Research · 13 september 2024
Preoperatieve ribociclib-letrozol versus chemotherapie: QoL FELINE analyse
European journal of cancer (Oxford, England : 1990) · 2022-10
AKT-signalering en biomarkers bij neoadjuvant ipatasertib bij TNBC: FAIRLANE analyse
Clinical cancer research : an official journal of the American Association for Cancer Research · 1 maart 2022
Palbociclib plus trastuzumab bij HER2-positief gevorderd mammacarcinoom: SOLTI-1303 PATRICIA fase II
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 november 2020
Multivariabele prognostische score bij HER2-positief vroeg mammacarcinoom
The Lancet. Oncology · 2020-11
Ribociclib plus letrozol versus chemotherapie bij postmenopauzaal HR-positief mammacarcinoom: RIGHT Choice
The Lancet. Oncology · 2020-01